Human ARD1A (NAA10) activation kit by CRISPRa
CAT#: GA105457
NAA10 CRISPRa kit - CRISPR gene activation of human N(alpha)-acetyltransferase 10, NatA catalytic subunit
CNY 12,255.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | NAA10 |
Locus ID | 8260 |
Kit Components | GA105457G1, ARD1A gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA105457G2, ARD1A gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA105457G3, ARD1A gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Disclaimer | These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_001256119, NM_001256120, NM_003491 |
Synonyms | ARD1; ARD1A; ARD1P; DXS707; MCOPS1; NATD; OGDNS; TE2 |
Summary | N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN401354 | NAA10 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8,680.00 |